Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Return on Equity (2020 - 2025)

Historic Return on Equity for Biodesix (BDSX) over the last 6 years, with Q3 2025 value amounting to 136.86%.

  • Biodesix's Return on Equity rose 1382200.0% to 136.86% in Q3 2025 from the same period last year, while for Sep 2025 it was 136.86%, marking a year-over-year increase of 1382200.0%. This contributed to the annual value of 3.36% for FY2024, which is 6800.0% up from last year.
  • According to the latest figures from Q3 2025, Biodesix's Return on Equity is 136.86%, which was up 1382200.0% from 6.8% recorded in Q2 2025.
  • In the past 5 years, Biodesix's Return on Equity ranged from a high of 136.86% in Q3 2025 and a low of 32.47% during Q4 2023
  • In the last 5 years, Biodesix's Return on Equity had a median value of 2.51% in 2025 and averaged 10.58%.
  • Within the past 5 years, the most significant YoY rise in Biodesix's Return on Equity was 1382200bps (2025), while the steepest drop was -1015600bps (2025).
  • Quarter analysis of 5 years shows Biodesix's Return on Equity stood at 2.54% in 2021, then plummeted by -161bps to 6.63% in 2022, then tumbled by -390bps to 32.47% in 2023, then surged by 95bps to 1.75% in 2024, then soared by 7900bps to 136.86% in 2025.
  • Its Return on Equity stands at 136.86% for Q3 2025, versus 6.8% for Q2 2025 and 2.51% for Q1 2025.